SGYP

In a research report released today, Rodman & Renshaw analyst Ram Selvaraju reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a …

In a research report released yesterday, Rodman & Renshaw analyst Ram Selvaraju initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and price …

In a research report released this morning, Canaccord analyst Corey Davis reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with a …

Recently, various executives have taken part in insider selling activity for the stocks of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Palo Alto Networks Inc (NYSE:PANW),LinkedIn Corp (NYSE:LNKD), and Skyworks Solutions …

Recently, various executives have taken part in insider trading activity for the stocks of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Celgene Corporation (NASDAQ:CELG), Cytosorbents Corp (NASDAQ:CTSO), and Amedica Corporation (NASDAQ:AMDA). Synergy Pharmaceuticals Inc …

In a research report published today, BTIG analyst Tim Chiang initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and …

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is going through rough times in the market at the moment after missing expectations with regard to their most …

Synergy Pharmaceuticals Synergy Pharmaceuticals Inc (NASDAQ:SGYP) had an incredible day in the market yesterday after announcing the results of it’s second of two …

FireEye Inc (NASDAQ:FEYE) shares are falling 3.83% to $45.

Canaccord analyst Corey Davis came out today with a favorable report on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the company announced positive top-line results from the second of …